5–10 g/day, increasing gradually to avoid gas.
Improves glycemic control (lowers fasting glucose, HbA1c, and HOMA-IR) in prediabetes and type 2 diabetes.
View the study (meta-analysis) →As a prebiotic it favors bifidobacteria and bowel regularity.
View the study (RCT) →⏱ 3 min read
Inulin is a fermentable soluble fiber of the fructan family, found naturally in roots and tubers such as chicory (the most concentrated commercial source), artichoke, garlic, onion, leek, asparagus, and green bananas; what makes it especially interesting in modern nutrition is its behavior as a selective prebiotic: it passes intact through the stomach and small intestine, reaches the colon where it is fermented by specific bacteria (especially bifidobacteria), and produces short-chain fatty acids such as butyrate, propionate, and acetate with systemic effects on metabolism, inflammation, and immune function.
Unlike probiotics (live bacteria ingested in the hope of colonizing the gut), prebiotics such as inulin selectively feed the beneficial bacteria that already live in our colon, a strategy that many consider more efficient in the long term because it modulates microbial composition without depending on the survival and colonization of exogenous strains.
The most solid evidence on inulin is its ability to increase the relative abundance of bifidobacteria in the colon: several clinical trials have shown significant increases in Bifidobacterium with doses of 5-15 grams daily over 2-4 weeks, along with increases in Faecalibacterium prausnitzii and other butyrate-producing bacteria; these changes are accompanied by improvements in markers of intestinal barrier function and low-grade systemic inflammation in people with intestinal dysbiosis.
The bifidogenic effect of inulin is one of the most reproducible of any prebiotic studied, which makes it a reasonable first-line option for people who want to improve microbial composition without resorting to live probiotics, whose efficacy depends heavily on the specific strain and the quality of the product.
In people with type 2 diabetes or prediabetes, several trials have shown modest but significant reductions in fasting glucose and HbA1c with prolonged use at doses of 10-30 grams daily; on lipid profile, the effects are small (modest reductions in total cholesterol and LDL) but consistent with the fermentative effect and the production of hepatic propionate, which modulates cholesterol synthesis.
In satiety and weight control, inulin raises plasma levels of satiety peptides (GLP-1, PYY) released by enteroendocrine cells in the colon in response to the short-chain fatty acids produced by its fermentation, an effect that translates into modest reductions in spontaneous caloric intake and small weight losses in studies lasting several weeks.
As a fermentable soluble fiber, inulin improves stool frequency and consistency in chronic functional constipation; the effects are comparable to those of psyllium, although inulin has the added advantage of a prebiotic effect and the disadvantage of producing more gas and abdominal bloating, especially at the start of treatment, which some people do not tolerate well.
The doses studied range from 3 to 30 grams daily, ideally starting with 3-5 grams daily and increasing gradually over several weeks so the microbiota can adapt without generating excessive gas and bloating; it is sold as a powder (dissolved in water, juices, smoothies, or yogurt), in capsules (with small doses per capsule, which makes it impractical for high doses), or as an ingredient added to functional foods.
Generally well tolerated when introduced gradually; the most common adverse effects are flatulence, abdominal bloating, borborygmi, and mild cramping at the start (especially with high initial doses); people with irritable bowel syndrome (IBS), and especially diarrhea-predominant IBS, may tolerate it poorly because inulin is a FODMAP (fermentable fructan) that can precipitate symptoms; people with SIBO (small intestinal bacterial overgrowth) should avoid it for the same reason until the underlying overgrowth has been treated.
Information, not medical advice. Scientific evidence reflects the quality of the studies.